首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

2077946

溶栓治療市場：依藥物類型、適應症、最終用戶、給藥途徑、通路、病患年齡、包裝、應用、劑型和地區分類

Fibrinolytic Therapy Market By Drug Type, By Indication, By End User, By Administration (Intravenous, Intra-arterial ), By Distribution Channel, By Patient Age, By Packaging Type, By Application, By Dosage Form, By Region

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，溶栓治療市場規模將達到 390.6 億美元，到 2033 年將達到 510.5 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 3.9%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	390.6億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	3.90%	預計金額（2033 年）	510.5億美元

溶栓療法用於溶解導致心肌梗塞和中風的血栓。雖然這是一種挽救生命的治療方法，但它並不能解決可能導致其他嚴重或疾病的潛在健康問題。溶栓療法通常靜脈注射注射給藥。當出現中風或心肌梗塞症狀，且其他治療方法（例如抗凝血劑和類固醇）無效時，才會使用溶栓療法。溶栓療法可以在家中或醫院進行。組織型胞漿素原原活化劑 (t-PA) 或Alteplase是溶栓療法中最常用的藥物，因為它能分解纖維蛋白和其他在體內形成血栓的物質。Tenecteplase對某些患者也有效，並且可以口服。

市場動態：

創傷和交通事故數量的增加推動了對纖溶藥物的需求，進而促進了纖溶治療市場的成長。這些藥物（主要用於口服治療月經月經）的日益普及預計也將進一步刺激市場成長。此外，嚴重交通事故和創傷數量的增加也催生了對抗纖溶藥物的需求，推動了市場成長。另外，這些藥物在治療血友病、血小板功能障礙、血管性血友病以及A型和B型血友病等疾病的應用日益廣泛，也進一步促進了市場成長。

此外，全球溶栓治療市場受到心血管、神經和肺部疾病（這些疾病會導致血栓）的盛行率上升所推動。根據世界衛生組織（WHO）統計，心血管疾病每年導致超過1790萬人死亡。此外，易患這些疾病的老年人口不斷增加也促進了市場成長。然而，溶栓藥物的高成本、嚴格的監管以及治療相關的出血風險阻礙了市場擴張。該市場為開發具有更高特異性、更強的纖維蛋白特異性和更低出血風險的有效重組變異、合成類似物和雜合分子提供了機會。

然而，這些藥物的高價格是可能阻礙市場成長的重要因素。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）介紹全球溶栓治療市場的主要公司。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球溶栓治療市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球溶栓治療市場中使用的各種策略矩陣來促進決策。

市場動態
- 促進因素
  - 心血管疾病發生率增加
  - 老年人口增加
  - 技術進步
  - 獲得醫療設施
- 抑制因子
  - 對特定患者群體療效的局限性
  - 出血併發症的風險
  - 替代療法的可近性
  - 時間限制和「從入院到治療」的延誤
- 機會
  - 新興市場
  - 聯合治療
  - 遠端醫療和遠端照護治療
  - 個人化醫療
- 主要亮點
- 監管趨勢
- 近期趨勢
- 產品上市及核准
- PEST分析
- 波特五力分析
- 企業合併、商業合作

第4章：全球溶栓治療市場

供給面和需求面分析
經濟影響

第5章：全球溶栓治療市場：依藥物類型分類（2021-2033 年）

Alteplase
萊特普拉澤
替那普酶
鏈球菌激酶
阿尼斯特雷普拉澤
尿激酶

第6章全球溶栓治療市場：依適應症分類（2021-2033 年）

急性缺血性腦中風
急性心肌梗塞
深層靜脈栓塞症
周邊動脈血栓症
其他動脈血栓症

第7章全球溶栓治療市場：依最終使用者分類（2021-2033 年）

醫院
門診手術中心
專科診所
其他

第8章全球溶栓治療市場：依給藥途徑分類（2021-2033 年）

靜脈注射（IV）
動脈內給藥（IA）

第9章全球溶栓治療市場：依通路分類（2021-2033 年）

醫院藥房
零售藥房
網路藥房

第10章全球溶栓治療市場：依病患年齡分類（2021-2033 年）

成年患者
兒童患者

第11章全球溶栓治療市場：依包裝類型分類（2021-2033 年）

管瓶
安瓿
預填充式注射器

第12章全球溶栓治療市場：依應用領域分類（2021-2033 年）

緊急醫療護理
介入心臟病學
血栓症治療
其他

第13章全球溶栓治療市場：依劑型分類（2021-2033 年）

用於復溶的冷凍乾燥粉末
注射液

第14章全球溶栓治療市場：依地區分類（2021-2033 年）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第15章競爭格局

公司簡介
- Genentech, Inc.（Roche）
- Bayer AG
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Bristol Myers Squibb Company
- Novarts AG
- AstraZeneca PLC
- Johnson & Johnson
- Daiichi Sankyo Company, Limited
- Merck & Co., Inc.
- Sanofi SA
- Takeda Pharmaceutical Company Limited
- Abbott Laboratories
- Mallinckrodt Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation
分析師意見

第16章

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI5879

Fibrinolytic Therapy Market is estimated to be valued at USD 39.06 Bn in 2026 and is expected to reach USD 51.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 39.06 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.90%	2033 Value Projection:	USD 51.05 Bn

Fibrinolytic therapy is used to dissolve blood clots that cause heart attacks or strokes. It is a lifesaving treatment, but it fails in underlying health problems that can lead to other serious diseases and conditions. Thrombolysis is usually given through an intravenous line. It is used when symptoms of a stroke or heart attack are present and the patient is not responding to other treatments, like anticoagulants and steroid medications. It can be given at home or in a hospital. Tissue plasminogen activator or alteplase is a drug that breaks down fibrin and other substances that create clots in the body that is most commonly used for thrombolysis. The drug tenecteplase is also effective in some patients, and it can also be given by mouth.

Market Dynamic:

The increasing incidences of trauma and road accidents are driving the demand for antifibrinolytic drugs, which in turn is fuelling fibrinolytic therapy market growth. The growing use of these drugs in oral bleeding treatments, mainly for menorrhagia (heavy menstrual flow) is again anticipated to bolster the market growth further. Moreover, rising incidences of severe road accidents and trauma is creating demand for anti-fibrinolytic drugs, thereby propelling the market growth. Furthermore, rising adoption of these drugs for treating hemophilia and other conditions such as platelet dysfunctions, Von Willebrand diseases and haemophilia A and B is further bolstering the market growth.

Also, the global fibrinolytic therapy market is driven by the rising prevalence of cardiovascular diseases, neurological disorders and pulmonary diseases causing blood clots. As per World Health Organization (WHO), cardiovascular diseases accounts for over 17.9 Mn deaths annually. Moreover, growing geriatric population prone to such diseases contributes to the market growth. However, high costs of fibrinolytic drugs, stringent regulations, and risk of bleeding associated with the therapy inhibits the market expansion. The market provides opportunities for development of effective recombinant variants, synthetic analogs, and hybrid molecules with greater specificity, enhanced fibrin specificity and reduced bleeding risks.

However, the high price of these drugs is a key factor that can hinder the market growth.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fibrinolytic therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, and Mitsubishi Tanabe Pharma Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global fibrinolytic therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibrinolytic therapy market

Detailed Segmentation:

Global Fibrinolytic Therapy Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
Alteplase
Reteplase
Tenecteplase
Streptokinase
Anistreplase
Urokinase
Global Fibrinolytic Therapy Market, By Indication:
Acute Ischemic Stroke
Acute Myocardial Infarction
Deep Vein Thrombosis
Peripheral Arterial Thrombosis
Other Arterial Thrombosis
Global Fibrinolytic Therapy Market, By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Global Fibrinolytic Therapy Market, By Administration:
Intravenous (IV)
Intra-arterial (IA)
Global Fibrinolytic Therapy Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Fibrinolytic Therapy Market, By Patient Age:
Adult Patients
Pediatric Patients
Global Fibrinolytic Therapy Market, By Packaging Type:
Vials
Ampoules
Pre-filled Syringes
Global Fibrinolytic Therapy Market, By Application:
Emergency Care
Interventional Cardiology
Thrombosis Treatment
Others
Global Fibrinolytic Therapy Market, By Dosage Form:
Lyophilized Powder for Reconstitution
Solution for Injection
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in the Global Fibrinolytic Market:
Genentech, Inc. (Roche)
Bayer AG
Boehringer Ingelheim International GmbH
Pfizer Inc.
Bristol Myers Squibb Company
Novartis AG
AstraZeneca PLC
Johnson & Johnson
Daiichi Sankyo Company, Limited
Merck & Co., Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Abbott Laboratories
Mallinckrodt Pharmaceuticals
Mitsubishi Tanabe Pharma Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Patient Age
- Market Snippet, By Packaging Type
- Market Snippet, By Application
- Market Snippet, By Dosage Form
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
  - Increasing incidence of cardiovascular diseases
  - Growing geriatric population
  - Technological advancements
  - Access to healthcare facilities
- Restrain
  - Limited efficacy in certain patient populations
  - Risk of bleeding complications
  - Availability of alternative treatment modalities
  - Time sensitivity and door-to-needle delays
- Opportunities
  - Emerging markets
  - Combination therapies
  - Telemedicine and remote treatment
  - Personalized medicine
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Mergers, Acquisitions, and Collaborations

4. Global

Supply Side and Demand Side Analysis
Economic Impact

5. Global Fibrinolytic Therapy Market, By Drug Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Alteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Reteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Tenacteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Streptokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Anistreplase
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Urokinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Fibrinolytic Therapy Market, By Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Acute Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Acute Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Deep Vein Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Peripheral Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Other Arterial Thrombosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,US$ Bn(US$ Bn)

7. Global Fibrinolytic Therapy Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Fibrinolytic Therapy Market, By Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Intra-arterial (IA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Global Fibrinolytic Therapy Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

10. Global Fibrinolytic Therapy Market, By Patient Age, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

11. Global Fibrinolytic Therapy Market, By Packaging Types, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

12. Global Fibrinolytic Therapy Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Emergency Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Interventional Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Thrombosis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

13. Global Fibrinolytic Therapy Market, By Dosage Form, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Lyophilized Powder for Reconstitution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Solution for Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

14. Global Fibrinolytic Therapy Market , By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2021 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 €"2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - South Africa
  - Central Africa
  - North Africa

15. Competitive Landscape

Company Profile
- Genentech, Inc. (Roche)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bristol Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novarts AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Daiichi Sankyo Company, Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mallinckrodt Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mitsubishi Tanabe Pharma Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views